TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathologic Complete Response to Pertuzumab and Trastuzumab in Breast Cancer.

Name: TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathologic Complete Response to Pertuzumab and Trastuzumab in Breast Cancer.
Author: Connolly, Roisin M

TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathologic Complete Response to Pertuzumab and Trastuzumab in Breast Cancer. — المؤلف: Connolly, Roisin M — Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20200217

المؤلف: Connolly, Roisin M
النشر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20200217
الوصف: 714-722 p.
الموضوعات: Adult؛ Aged؛ Aged, 80 and over؛ Antibodies, Monoclonal, Humanized؛ Antineoplastic Combined Chemotherapy Protocols؛ Breast Neoplasms؛ Chemotherapy, Adjuvant؛ Female